These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8902158)

  • 21. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
    Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
    Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease.
    Tilly-Kiesi M; Syvänne M; Kuusi T; Lahdenperä S; Taskinen MR
    J Lipid Res; 1992 Mar; 33(3):333-42. PubMed ID: 1569383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis.
    Drexel H; Aczel S; Marte T; Vonbank A; Saely CH
    Atherosclerosis; 2010 Feb; 208(2):484-9. PubMed ID: 19748621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes?
    Snehalatha C; Ramachandran A; Sivasankari S; Satyavani K; Viswanathan V; Misra J; Girinath MR; Sathyamurthy I
    J Assoc Physicians India; 2002 Aug; 50():1036-8. PubMed ID: 12421026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of doxazosin, an alpha 1-adrenergic inhibitor, on plasma lipid and lipoprotein levels, low density lipoprotein metabolism and cholesterol absorption in cynomolgus monkeys.
    Stucchi AF; Vespa DB; Terpstra AH; Nicolosi RJ
    Atherosclerosis; 1993 Nov; 103(2):255-66. PubMed ID: 8292100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein e4 allele is predictor of coronary artery disease death in elderly patients with type 2 diabetes mellitus.
    Guang-da X; You-ying L; Zhi-song C; Yu-sheng H; Xiang-jiu Y
    Atherosclerosis; 2004 Jul; 175(1):77-81. PubMed ID: 15186949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LDL molecular size as risk factor in coronary artery disease.
    Kozma L; Fodor J; Chockalingam A; Sussex B
    Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDL subparticles and coronary artery disease in NIDDM.
    O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Kottke BA
    Atherosclerosis; 1996 Apr; 121(2):285-91. PubMed ID: 9125302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report.
    Syvänne M; Rosseneu M; Labeur C; Hilden H; Taskinen MR
    Atherosclerosis; 1994 Jan; 105(1):25-34. PubMed ID: 8155085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease.
    Nikkilä M; Solakivi T; Lehtimäki T; Koivula T; Laippala P; Aström B
    Atherosclerosis; 1994 Apr; 106(2):149-57. PubMed ID: 8060376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
    Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
    J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triglyceride as a risk factor for coronary artery disease.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance.
    Fujiwara R; Kutsumi Y; Hayashi T; Nishio H; Koshino Y; Shimada Y; Nakai T; Miyabo S
    Am J Cardiol; 1995 Jan; 75(2):122-6. PubMed ID: 7810485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid parameters in patients with acute coronary syndromes versus stable coronary artery disease.
    Vonbank A; Saely CH; Rein P; Drexel H
    Eur J Clin Invest; 2015 Oct; 45(10):1092-7. PubMed ID: 26255620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
    Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC
    Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.